All data are based on the daily closing price as of July 18, 2024
b

Bora Pharmaceuticals

6472.TWO
19.89 USD
0.07
+0.35%

Overview

Last close
19.89 usd
Market cap
2.02B usd
52 week high
24.81 usd
52 week low
10.44 usd
Target price
23.07 usd

Valuation

P/E
24.0938
Forward P/E
N/A
Price/Sales
4.2232
Price/Book Value
8.6545
Enterprise Value
2.20B usd
EV/Revenue
4.2495
EV/EBITDA
15.1896

Key financials

Revenue TTM
502.40M usd
Gross Profit TTM
89.82M usd
EBITDA TTM
160.60M usd
Earnings per Share
0.87 usd
Dividend
0.19 usd
Total assets
726.26M usd
Net debt
63.82M usd

About

Bora Pharmaceuticals Co., LTD. researches and develops, manufactures, distributes, and sells pharmaceuticals worldwide. The company operates through Sales, Contract Development & Manufacturing Organization, and Other segments. It manufactures and sells generic, brand, and over the counter (OTC) drugs. The company also offers contract development and manufacturing services, including clinical and commercial manufacturing, pharmaceutical development, packaging and serialization, analytical and microbiology testing, and regulatory affairs services. In addition, it provides food and vitamin supplements, and skincare products; and biotechnical services. The company sells its products directly to clinics, pharmacies, pharmacy chains, and drug stores, as well as through distributors to medical centers, corporate and public hospitals, and regional and district hospitals. Bora Pharmaceuticals Co., LTD. was incorporated in 2007 and is based in Taipei City, Taiwan.
  • Symbol
    6472.TWO
  • Exchange
    TWO
  • Isin
    TW0006472004
  • Country
    Taiwan
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
    Mr. Pao-Shi Sheng
  • Headquarter
    Taipei
  • Web site
    https://www.bora-corp.com
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top